Literature DB >> 11298599

Reduced memory B-cell populations in boys with B-cell dysfunction after bone marrow transplantation for X-linked severe combined immunodeficiency.

S S Ting1, S G Tangye, J Wood, R A Ffrench, J B Ziegler.   

Abstract

X-linked severe combined immunodeficiency (XSCID) is a lethal disease resulting in death in infancy. In many instances, haploidentical bone marrow transplantation (BMT) offers reconstitution of T-cell immunity alone, with residual hypogammaglobulinaemia. The exact nature of B-cell dysfunction in these patients is unclear, although differentiation arrest of the B cells is a potential explanation. To ascertain the differentiation status of peripheral blood B lymphocytes from XSCID patients after BMT, the surface expression of CD19, CD10, CD34, CD5, serum immunoglogulin (sIg)M, sIgD, sIgG and CD27 on these B cells was investigated using three-colour flow cytometry. CD27 is a marker of memory B cells. Populations of CD19+IgM-D- B cells, CD19+IgM-only, CD19+IgG+CD27+ and CD19+IgM+ CD27+ B cells were found to be diminished in the XSCID patients after BMT with persistent hypogammaglobulinaemia, compared with both post-BMT patients with B-cell function and age-matched normal controls. This indicated the lack of CD19+IgM-D- B cells, which represent Ig isotype-switched B cells, as well as CD19+IgM-only and CD19+IgG+CD27+ or CD19+IgM+CD27+ memory B-cell populations. Interaction between CD27 and its ligand CD70 has been shown to induce IgG and IgM production by CD27+ B cells. Therefore, the lack of CD27/70 interaction is a probable explanation for the hypogammaglobulinaemia in these patients after BMT.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11298599     DOI: 10.1046/j.1365-2141.2001.02639.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  IL-21 is the primary common γ chain-binding cytokine required for human B-cell differentiation in vivo.

Authors:  Mike Recher; Lucinda J Berglund; Danielle T Avery; Morton J Cowan; Andrew R Gennery; Joanne Smart; Jane Peake; Melanie Wong; Sung-Yun Pai; Sachin Baxi; Jolan E Walter; Umaimainthan Palendira; Gillian A Tangye; Michael Rice; Shannon Brothers; Waleed Al-Herz; Hans Oettgen; Hermann Eibel; Jennifer M Puck; Federica Cattaneo; John B Ziegler; Silvia Giliani; Stuart G Tangye; Luigi D Notarangelo
Journal:  Blood       Date:  2011-10-28       Impact factor: 22.113

2.  Severe papillomavirus infection progressing to metastatic squamous cell carcinoma in bone marrow-transplanted X-linked SCID dogs.

Authors:  Michael H Goldschmidt; Jeffrey S Kennedy; Douglas R Kennedy; Hang Yuan; David E Holt; Margret L Casal; Anne M Traas; Elizabeth A Mauldin; Peter F Moore; Paula S Henthorn; Brian J Hartnett; Kenneth I Weinberg; Richard Schlegel; Peter J Felsburg
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

3.  T cell repertoire development in XSCID dogs following nonconditioned allogeneic bone marrow transplantation.

Authors:  William Vernau; Brian J Hartnett; Douglas R Kennedy; Peter F Moore; Paula S Henthorn; Kenneth I Weinberg; Peter J Felsburg
Journal:  Biol Blood Marrow Transplant       Date:  2007-08-02       Impact factor: 5.742

Review 4.  Immune deficiencies due to defects in cytokine signaling.

Authors:  John Kelly; Warren J Leonard
Journal:  Curr Allergy Asthma Rep       Date:  2003-09       Impact factor: 4.806

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.